Access cutting-edge cardiac sarcoidosis treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.
Access cardiac sarcoidosis specialists in New York at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cardiac sarcoidosis treatment provided free
Prospective randomized controlled trial comparing low dose Prednisone(or Prednisolone)/Methotrexate combination to standard dose Prednisone(or Prednisolone) in patients diagnosed with acute active clinically manifest cardiac sarcoidosis and not yet treated. The Investigators hypothesize that low dose Prednisone(or Prednisolone)/Methotrexate combination will be as effective as standard dose Prednisone(or Prednisolone), and result in significantly better quality of life and less toxicity than sta
Sponsor: Ottawa Heart Institute Research Corporation
Check if you qualify for this cardiac sarcoidosis clinical trial in New York, NY
If you're searching for cardiac sarcoidosis treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cardiac sarcoidosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.